Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3Unknown 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Glioblastoma 21Brain Neoplasms 15Central Nervous System Neoplasms 14Astrocytoma 9Glioma 7Oligodendroglioma 5Medulloblastoma 4Neoplasms 3Lymphoma 3Gliosarcoma 3Recurrence 2Melanoma 2Lymphoma, AIDS-Related 2Leukemia, Myeloid, Acute 2Uveal Melanoma 1Spinal Cord Neoplasms 1Solid Tumor 1Optic Nerve Glioma 1Newly Diagnosed High Grade Glioma 1Neuroectodermal Tumors 1Lung Neoplasms 1Intraocular Lymphoma 1Familial ependymoma 1Ependymoma 1Drug-Related Side Effects and Adverse Reactions 1Cognition Disorders 1Carcinoma, Non-Small-Cell Lung 1Camurati-Engelmann Syndrome 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 282Rituximab 260Etoposide 161Filgrastim 155Vincristine 145Doxorubicin 134Prednisone 117Cytarabine 108Radiotherapy 102Peripheral Blood Stem Cell Transplantation 90Methotrexate 90fludarabine phosphate 87Melphalan 78Busulfan 71Dexamethasone 59Granulocyte Colony-Stimulating Factor 56Carmustine 53fludarabine 51Bortezomib 46Tacrolimus 44Mycophenolic Acid 41Antilymphocyte Serum 41Ifosfamide 40Leucovorin 39Gemcitabine 38Whole-Body Irradiation 36Cyclosporine 35Bendamustine Hydrochloride 34sargramostim 33Methylprednisolone 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Lymphoma × Lomustine × Clear all
NCT00074191 2017-04-21

Protocol-A

OHSU Knight Cancer Institute

Phase 2 Completed
1 enrolled
Lymphoid

Lymphoma, Intraocular Lymphoma

NCT00003114 2010-06-11

Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease

Case Comprehensive Cancer Center

Phase 2 Completed
5 enrolled
Lymphoid

Lymphoma, Lymphoma, AIDS-Related

NCT00049439 2010-06-11

Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma

Case Comprehensive Cancer Center

Phase 2 Completed
54 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡